Drug Type Biosimilar, Monoclonal antibody |
Synonyms KN-005 |
Target |
Action antagonists |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anus Neoplasms | Phase 3 | China | - | |
Bladder Cancer | Phase 3 | China | - | |
Head and Neck Neoplasms | Phase 3 | China | - |